The nuclear cofactor receptor interacting protein-140 (RIP140) regulates the expression of genes involved in Aβ
Katrin Blondrath1, Jennifer H Steel2, Loukia Katsouri1
1Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK.
Abstract:
The receptor interacting protein-140 (RIP140) is a cofactor for several nuclear receptors and has been involved in the regulation of metabolic and inflammatory genes. We hypothesize that RIP140 may also affect Aβ generation because it modulates the activity of transcription factors previously implicated in amyloid precursor protein (APP) processing, such as peroxisome proliferator-activated receptor-γ (PPARγ). We found that the levels of RIP140 are reduced in Alzheimer's disease (AD) postmortem brains compared with healthy controls. In addition, in situ hybridization experiments revealed that RIP140 expression is enriched in the same brain areas involved in AD pathology, such as cortex and hippocampus. Furthermore, we provide evidence using cell lines and genetically modified mice that RIP140 is able to modulate the transcription of certain genes involved in AD pathology, such as β-APP cleaving enzyme (BACE1) and GSK3. Consequently, we found that RIP140 overexpression reduced the generation of Aβ in a neuroblastoma cell line by decreasing the transcription of β-APP cleaving enzyme via a PPARγ-dependent mechanism. The results of this study therefore provide molecular insights into common signaling pathways linking metabolic disease with AD.
Insights
Receptor interacting protein-140 (RIP140) levels are reduced in Alzheimer's disease (AD) brains. RIP140 may protect against AD by reducing amyloid-beta (Aβ) generation through a PPARγ-dependent mechanism.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Receptor interacting protein-140 (RIP140) is a cofactor regulating metabolic and inflammatory genes.
- RIP140's role in Alzheimer's disease (AD) pathogenesis is unknown, but it modulates transcription factors like PPARγ involved in amyloid precursor protein (APP) processing.
Purpose of the Study:
- To investigate the role of RIP140 in Alzheimer's disease (AD) and its potential impact on amyloid-beta (Aβ) generation.
Main Methods:
- Examined RIP140 levels in postmortem AD brains versus controls.
- Used in situ hybridization to determine RIP140 expression patterns in AD-affected brain regions.
- Employed cell lines and genetically modified mice to study RIP140's effect on AD-related gene transcription (BACE1, GSK3).
Main Results:
- RIP140 levels were decreased in AD brains.
- RIP140 expression was enriched in the cortex and hippocampus, areas affected by AD pathology.
- RIP140 modulated the transcription of BACE1 and GSK3.
- RIP140 overexpression reduced Aβ generation in neuroblastoma cells by decreasing BACE1 transcription via a PPARγ-dependent pathway.
Conclusions:
- RIP140 is implicated in Alzheimer's disease (AD) pathology.
- RIP140 may serve a protective role in AD by inhibiting amyloid-beta (Aβ) production.
- Findings suggest a link between metabolic signaling pathways and AD pathogenesis.
More Related Videos
10:10Use of Two Dimensional Semi-denaturing Detergent Agarose Gel Electrophoresis to Confirm Size Heterogeneity of Amyloid or Amyloid-like Fibers
Published on: April 26, 2018
09:52Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System
Published on: December 28, 2017
Related Concept Videos
Regulation of Nuclear Protein Sorting
Regulation of the Unfolded Protein Response
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Co-activators and Co-repressors
The Unfolded Protein Response
RNA Editing
